2 weeks Xenon Q3 Loss Narrower Than Expected, Pipeline Development in FocusZacks

XENE reports a narrower-than-expected third-quarter 2024 loss. Its development programs for azetukalner in epilepsy and MDD are progressing well.

Pharmaceuticals

12 hours Regeneron Pharmaceuticals, Inc. (REGN): Among the Most Promising Cancer Stocks According to Hedge FundsInsider Monkey X

15 hours 3 Reasons Why Buying Madrigal Pharmaceuticals Today Is a Wise MoveThe Motley Fool X

1 day Avadel Pharmaceuticals: Despite My Sympathies For The Company, Stock Looks RiskySeeking Alpha X

2 days Madrigal (MDGL) Just Flashed Golden Cross Signal: Do You Buy?Zacks X

2 days Is Atea Pharmaceuticals (AVIR) Stock Outpacing Its Medical Peers This Year?Zacks X

2 days Warren Buffett’s Stock Selling is Sending a Big SignalZacks X

2 days Goldman Sachs: Vertex Pharmaceuticals Incorporated (VRTX) Is A Top Growth Investor StockInsider Monkey X

2 days Got $500? 1 Biotech Stock to Buy and Hold ForeverThe Motley Fool X

2 days Why Is Ionis Pharmaceuticals, Inc. (IONS) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X

2 days Why Is Madrigal Pharmaceuticals, Inc. (MDGL) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X

2 days JAZZ Secures FDA Approval for Ziihera in Biliary Tract CancerZacks X

2 days PFE vs. NVO: Which Stock Is the Better Value Option?Zacks X

2 days MCK Stock Down Despite Latest Partnership to Boost SCD TreatmentZacks X

3 days Sun Pharmaceuticals Elliott Wave technical analysis [Video]FXStreet X

3 days ANI (ANIP) Upgraded to Buy: What Does It Mean for the Stock?Zacks X

3 days ARS Pharmaceuticals: Demand Curve Is Key UnknownSeeking Alpha X

4 days Acurx to add up to $1 million in bitcoin for treasury reserve, following MicroStrategy’s playbookCNBC X

4 days Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?Zacks X

4 days Regeneron Pharmaceuticals, Inc. (REGN) Jefferies London Healthcare Conference (Transcript)Seeking Alpha X

4 days Phathom Pharmaceuticals (PHAT) Upgraded to Buy: Here’s What You Should KnowZacks X

5 days Vertex Pharmaceuticals Incorporated (VRTX) Presents at Stifel 2024 Healthcare Conference (Transcript)Seeking Alpha X

5 days Here’s Why Regeneron Pharmaceuticals (REGN) Declined in Q3Insider Monkey X

5 days How Much Upside is Left in Rigel (RIGL)? Wall Street Analysts Think 28.28%Zacks X

5 days After Golden Cross, Milestone Pharmaceuticals (MIST)’s Technical Outlook is BrightZacks X

5 days Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock?Zacks X

5 days Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should KnowZacks X

5 days Silver Ring Value Partners: Jazz Pharmaceuticals (JAZZ) Is a “High Uncertainty With Low Risk” InvestmentInsider Monkey X

5 days Zacks.com featured highlights Rigel, Synchrony Financial, SkyWest, Allient and Rush Street InteractiveZacks X

5 days NRx Pharmaceuticals, Inc. (NRXP) Q3 2024 Earnings Call TranscriptSeeking Alpha X

5 days Elite Pharmaceuticals’ Stock Up Despite Q2 Earnings DeclineZacks X

6 days Jazz Pharmaceuticals: High Uncertainty, Low RiskSeeking Alpha X

6 days Wall Street Analysts Believe Tarsus Pharmaceuticals (TARS) Could Rally 41.09%: Here’s is How to TradeZacks X

6 days Here’s Why Ionis Pharmaceuticals (IONS) is Poised for a Turnaround After Losing -13.46% in 4 WeeksZacks X

6 days ALNY Reports Sustained 6-Month Efficacy Data From Amyloidosis StudyZacks X

6 days What Makes Eton Pharmaceuticals (ETON) a Good Fit for ‘Trend Investing’Zacks X

6 days Is Jazz Pharmaceuticals plc (JAZZ) the Best Immunotherapy Stock to Buy Now?Insider Monkey X

1 week Elite Pharmaceuticals, Inc. (ELTP) Q2 2025 Earnings Conference Call TranscriptSeeking Alpha X

1 week Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?The Motley Fool X

1 week Inovio Pharmaceuticals (INO) Q3 2024 Earnings Call TranscriptThe Motley Fool X

1 week Inovio Pharmaceuticals, Inc. (INO) Q3 2024 Earnings Call TranscriptSeeking Alpha X

1 week Inovio Pharmaceuticals, Inc. 2024 Q3 – Results – Earnings Call PresentationSeeking Alpha X

1 week 60 Degrees Pharmaceuticals Inc. (SXTP) Reports Q3 Loss, Misses Revenue EstimatesZacks X

1 week Syros Stock Plunges as Lead Cancer Study Fails to Meet Primary GoalZacks X

1 week 2 Top Growth Stocks to Buy on the DipThe Motley Fool X

1 week New Strong Buy Stocks for November 14thZacks X

1 week EyePoint Pharmaceuticals: Low Price And Good Data Create An OpportunitySeeking Alpha X

1 week Tarsus Pharmaceuticals, Inc. (TARS) Q3 2024 Earnings Call TranscriptSeeking Alpha X

1 week X4 Pharmaceuticals, Inc. 2024 Q3 – Results – Earnings Call PresentationSeeking Alpha X

1 week X4 Pharmaceuticals, Inc. (XFOR) Q3 2024 Earnings Call TranscriptSeeking Alpha X

More news +